Options Volatility and Implied Earnings Moves Today, July 31, 2026Tip Ranks·54 minutes agoENB+0.53%XOM+0.14%
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6Bbiopharmadive·56 minutes agoJNJ-3.66%
EU grants Merck Animal Health marketing authorization for Nobivac NXT HCPChFeLV cat vaccinePUBT·1 hour agoMRK-0.44%
Vestor Capital LLC Has $26.60 Million Holdings in Merck & Co., Inc. $MRKMarket Beat·1 hour agoMRK-0.44%
GTS Financial LLC Makes New Investment in Eli Lilly and Company $LLYMarket Beat·3 hours agoLLY-4.55%ELIS0.00%
Resilience and Lilly to increase US medicines production with $750m investmentPharmaceutical Technology·3 hours agoLLY-4.55%ELIS0.00%
AbbVie Reports Second-Quarter 2026 Financial Results | ABBV Stock NewsStockTitan·8 hours agoABBV-2.24%APGE+7.00%
Behzad Aghazadeh Holds Board Seat at Scribe Therapeutics with 16.37% StakeTradingView·10 hours agoSCTX+11.11%LLY-4.55%
Eli Lilly and Company (NYSE:LLY) Trading Down 4.5% - Time to Sell?Market Beat·14 hours agoLLY-4.55%LLYZ0.00%
Eli Lilly & Co. Stock Underperforms Thursday When Compared To CompetitorsMarketWatch Automated·15 hours agoLLY-4.55%LLYZ0.00%
Johnson & Johnson Stock (JNJ) Moved Down by 3.49% on Jul 30: Key Drivers UnveiledTradingKey·19 hours agoJNJ-3.66%
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Dealsbenzinga_article·20 hours agoJNJ-3.66%
